Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Walmart Faces a Justice Department Opioid Lawsuit

By Rhian Hunt - Dec 22, 2020 at 4:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The government alleges the retailer's practices are worsening the crisis.

The U.S. Department of Justice (DOJ) launched a lawsuit against giant retailer Walmart ( WMT 1.51% ) today, as reported by multiple sources. While the accusations are not new, today's filing represents direct legal action. The Drug Enforcement Agency (DEA) has also weighed in, claiming Walmart's pharmacies have been regularly filling prescriptions it describes as "illegitimate."

As reported by USA Today, the DOJ's Civil Division head, Jeffrey Bossert Clark, alleges Walmart engaged in unlawful conduct that "contributed to the epidemic of opioid abuse throughout the United States." The government agency states Walmart failed to do its due diligence in checking on the validity of prescriptions, and did not report those that appeared suspicious.

White pills spilling out of a plastic prescription medication bottle.

Image source: Getty Images.

Walmart responded with several counterclaims, saying it "sent DEA tens of thousands of investigative leads" and "blocked thousands of questionable doctors." It claims the DEA is simply looking to shift the blame for its own failures onto pharmacies and pharmacists. According to its statement, the agency has a record of "well-documented failures in keeping bad doctors from prescribing opioids" and says the case has "factual inaccuracies and cherry-picked documents" as its basis.

Walmart's pharmacy network, which includes more than 5,000 in-store locations across America, was recently chosen by the federal government as one of the major chains to help with distribution of the new COVID-19 vaccines. The company has made major gains this year as its smaller competitors were shut down as nonessential, while the giant retailer was allowed to stay open, speeding the concentration of retail into the hands of just a few players such as Walmart, Amazon, and Costco

The DOJ's current lawsuit could cost the retailer billions of dollars in penalties if successful, UPI reports.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Wal-Mart Stores, Inc. Stock Quote
Wal-Mart Stores, Inc.
$137.51 (1.51%) $2.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.